Your search matched 168 results
The main screen at the Lions Health Festival at Cannes showed the newest player in the fast-changing world of social media healthcare communications: social media interactions with measurable KPIs.
Chris Iafolla, Head of Digital and Social Strategy for Syneos Health Communications shares insights on recruiting patients into clinical trials via social media.
In recent years, many have questioned social media’s impact on mental health, but a recent study conducted by psychologists at UPenn stands as the first to establish a causal relationship between social media usage and decreased well-being.
Social Media’s Eroding Trust Hits Healthcare Companies | In The Media
The pharmaceutical and biotech world has a reputation problem, and the practice of using social media to engender trust among stakeholders has been beset by its own recent challenges, as those social channels too have now fallen under public scrutiny.
Marie Emms, Rowena Kam, and Michael Pearlman of Syneos Health discuss how social media can be used by patients with rare diseases and by those who recruit for rare disease clinical trials.
You’re not missing out in your use of social media in pharma comms, says Duncan Arbour, our SVP Innovation, Europe.
As many of us are in the throws of planning and executing trade shows in the coming months, I thought this study from Freeman XP might come in handy.
Julian Suchman, Digital & Social Strategy, inVentiv Health PR, takes a closer look at the new communication priorities required to thrive in the new value landscape.
In this session of efp Barcelona 2020, two of the biggest names in pharma, MSD and Roche, shared their own unique digital experiences in hopes of teaching and inspiring others.
FiercePharma recapped the social media buzz and highlights from Cannes Lions Health this past weekend, including inVentiv Health Communications' presentation on social centricity.
How Long Does It Take to Go from ‘like’ to ‘Hate’? | In The Media
Duncan Arbour, SVP Innovation, Syneos Health Communications Europe, shares his thoughts on social media regulation and says that pharma’s ‘move slowly and take care’ approach to social media may not have been such a bad thing after all.
It’s not often that a social media strategy idea really goes viral – let alone gets 752 million social impressions, tens of thousands of interactions, international media coverage and a letter from the FDA.
The overlooked heroes in healthcare are often clinical trial participants.
42% of online adults use multiple social media sites and those who choose only 1, typically use Facebook according to Pew Research.
In 2014, the FDA mandated that a prescription drug’s benefit and risk information had to appear in its entirety when promoting via social media channels.
Deploying ambassadors to speak at the marketing conference DigiPharma Connect, Snapchat is vying to position itself as the best social media outlet for pharma marketing.
The Changing Face of Social Media Marketing | In The Media
In this PM360 article, Chris Iafolla, Head of Digital & Social Strategy at Syneos Health Communications, comments on the usage of chatbot technology in the pharmaceutical industry.
Earlier this year, Wego Health launched a new platform that connects patients with healthcare entities with one goal: connect the patient’s experience with said entity to the patient’s social networks.
At this point, if you utilize any of the popular social media platforms, you are fully aware of the ‘tweet heard around the world’, the response from the maker of Ambien, Sanofi, and the public’s response.
A new study by a graduate student with the Harvard University psychology department reports that social media posts can provide clues as to whether or not a user is likely to suffer from depression.
As pharma becomes more and more ingrained in social media, it’s critical to know how and where to listen to the community that you are engaging with and to understand that this is an ongoing, individualized process.
Patient “opinion leaders” or “thought leaders” are often leveraged as an amplifier of messages around a specific indication on behalf of pharma companies.
HOW TO SURVIVE AND THRIVE IN THE AGE OF MODERN ACTIVISM | Perspectives
Social media offers incredible power to engage stakeholders, but also gives exposure to those who don’t agree with you or seek change.
Patients are moving away from social media and seeking information on channels not typically associated with patient recruitment – forums.
The #1 Thing We Do Online? | Blog
Social media is now the #1 thing we do online.
Ogilvy recently released a report on pharma’s use of social media in 2014: Connecting the Dots.
Key Questions About Social Media in 2019 | In The Media
In this PM360 article, Julian Suchman, Digital Strategist at Syneos Health, talks about why Facebook remains an effective channel for pharma marketers in 2019.
Federal Trade Commission has released a new guide: “Disclosures 101 for Social Media Influencers”.
In this PRWeek/MM&M Health Influencer 50 feature, Jessica Birardi, Senior Influencer Strategist at Syneos Health shares: "For celebrities on social media, if I believe that they’re real, I’m all in.
AstraZeneca has been investing in supporting people via social media for 6 years.